In Focus

  • 21 October 2020 - Over 159,000 viral genomic sequences of hCoV-19 shared via GISAID with unprecedented speed

    Over 159,000 viral genomic sequences of hCoV-19 shared with unprecedented speed via GISAID

    Since the start of the COVID-19 outbreak and the identification of the pandemic virus, laboratories around the world are generating viral genome sequence data with unprecedented speed, enabling real-time progress in the understanding of the new disease and in the research and development of candidate medical countermeasures. Sequence data are essential to design and evaluate diagnostic tests, to track and trace the ongoing outbreak, and to identify potential intervention options. Listen to PRI's Elana Gordon.

    GISAID data Submitters and Curators ensure real-time data sharing of hCoV-19 remains reliable, to enable rapid progress in the understanding of the new COVID-19 disease and in the research and development of candidate medical countermeasures.

  • 25 September 2020

    Recommended composition of influenza virus vaccines for use in the 2021 Southern Hemisphere influenza season announced

    Experts taking part in the WHO vaccine composition and information meeting (VCM) between 16-24 September 2020, organized by the WHO Global Influenza Programme, announced on 25. September the recommended components for vaccines for the 2021 Southern Hemisphere influenza season.

    These recommendations are used by the national vaccine regulatory agencies and the pharmaceutical companies to develop, produce and license influenza vaccines.

    read more:

  • 4 July 2020 - Clade and lineage nomenclature aids in genomic epidemiology

    Clade and lineage nomenclature aids in genomic epidemiology studies of active hCoV-19 viruses

    Due to the naturally expanding genetic diversity of hCoV-19 viruses, GISAID introduced a nomenclature system for major clades, based on marker mutations within 6 high-level phylogenetic groupings from the early split of S and L, to the further evolution of L into V and G and later of G into GH and GR.

    GISAID clades were subsequently augmented with more detailed lineages assigned by the Phylogenetic Assignment of Named Global Outbreak LINeages (PANGOLIN) tool, and a third effort using a Year-Letter nomenclature to facilitate discussion of large-scale diversity patterns of hCoV-19, to aid in the understanding of patterns and determinants of the global spread of the pandemic strain causing COVID-19.  > read more

  • CBD Study finds GISAID might provide useful lessons and insight to ABS discussion

    CBD Study finds 'GISAID might provide useful lessons and insight to ABS discussions'

    A peer-reviewed fact-finding and scoping study on digital sequence information on genetic resources in the context of the Convention on Biological Diversity and the Nagoya Protocol, highlights key advantages of GISAID’s sharing mechanism and a fair and equitable benefit-sharing resulting from access to data.

    With the core principals of timely international sharing of health data for protecting populations against lethal infectious disease outbreaks and adherence to scientific etiquette of acknowledgement of the source of data has resulted in global trust and confidence in GISAID. 

    > download the fact-finding & scoping study

  • 19 May 2017 G20 Health Ministers

    G20 Health Ministers recognize the importance of GISAID in regard to virus data sharing

    At the invitation of Germany, the first meeting of Health Ministers of the Group of Twenty leading industrialized and emerging economies (G20) took place in Berlin between 19-20 May 2017.

    Under the banner of “Together Today for a Healthy Tomorrow – Joint Commitment for Shaping Global Health”, the two-day meeting focused on combating global health hazards. In their Berlin Declaration, the G20 Health Ministers recognize the importance of the Global Initiative on Sharing All Influenza Data (GISAID).

    > read more
    > The Berlin Declaration of the G20 Health Ministers (2017)

 

 

Interactive Real-Time Mutation Tracker

Michigan State University (USA)
Explore and animate mutations over time

Interactive Real-Time Mutation Tracker

Michigan State University (USA)
Explore and animate mutations over time

Public-Private Partnerships of the GISAID Initiative

The GISAID Initiative, originally known as a Global Initiative on Sharing All Influenza Data, involves public-private-partnerships between the Initiative's administrative arm Freunde of GISAID e.V., a registered non-profit association, and governments of the Federal Republic of Germany, the official host of the GISAID platform, Singapore and the United States of America, with support from private and corporate philanthropy.